Annual Drug Patent Expirations for JEVTANA+KIT Jevtana Kit is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Sanofi Aventis drug JEVTANA KIT appeared fir…
New patent expiration for Sanofi Aventis drug JEVTANA KIT Read Post »
This chart shows the pharmaceutical companies with the most patents in Portugal. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pat…
Which pharmaceutical companies have the most drug patents in Portugal? Read Post »
Annual Drug Patent Expirations for GIAPREZA Giapreza is a drug marketed by La Jolla Pharma and is included in one NDA. It is available from one supplier. There are eight…
The post New patent for La Jolla drug GIAPREZA appeared first on DrugPatentWatch …
Annual Drug Patent Expirations for IMVEXXY Imvexxy is a drug marketed by Therapeuticsmd Inc and is included in one NDA. It is available from one supplier. There are twelve patents…
The post New patent for Therapeuticsmd Inc drug IMVEXXY appeared first …
Annual Drug Patent Expirations for GENOSYL Genosyl is a drug marketed by Vero Biotech and is included in one NDA. There are nineteen patents protecting this drug. This drug has…
The post New patent for Vero Biotech drug GENOSYL appeared first on DrugPa…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Spain. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical c…
Which pharmaceutical companies have the most SPCs in Spain? Read Post »
Annual Drug Patent Expirations for BIJUVA Bijuva is a drug marketed by Therapeuticsmd Inc and is included in one NDA. It is available from one supplier. There are sixteen patents…
The post New patent for Therapeuticsmd Inc drug BIJUVA appeared first on…
Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are twenty-two patents protecting…
The post New patent for NOVO drug SAXENDA appeared first on DrugPaten…
Annual Drug Patent Expirations for SILENOR Silenor is a drug marketed by Currax and is included in one NDA. It is available from three suppliers. There are twelve patents protecting…
The post New patent for Currax drug SILENOR appeared first on DrugPat…
Annual Drug Patent Expirations for ONIVYDE Onivyde is a drug marketed by Ipsen Inc and is included in one NDA. It is available from one supplier. There are sixteen patents…
The post New patent for Ipsen Inc drug ONIVYDE appeared first on DrugPatentWatc…
Get new actionable insights and updates from BiotechBlog
